194 related articles for article (PubMed ID: 16217075)
1. Primary central nervous system lymphomas (PCNSL): MRI response criteria revised.
Küker W; Nägele T; Thiel E; Weller M; Herrlinger U
Neurology; 2005 Oct; 65(7):1129-31. PubMed ID: 16217075
[TBL] [Abstract][Full Text] [Related]
2. Primary central nervous system lymphomas (PCNSL): MRI response criteria revised.
Schlegel U; Jürgens A; Pels H
Neurology; 2006 Apr; 66(8):1287; author reply 1287. PubMed ID: 16636266
[No Abstract] [Full Text] [Related]
3. Primary central nervous system lymphoma: monocenter, long-term, intent-to-treat analysis.
Kiewe P; Fischer L; Martus P; Thiel E; Korfel A
Cancer; 2008 Apr; 112(8):1812-20. PubMed ID: 18318432
[TBL] [Abstract][Full Text] [Related]
4. Magnetic resonance features of primary central nervous system lymphoma in the immunocompetent patient: a pictorial essay.
Yap KK; Sutherland T; Liew E; Tartaglia CJ; Pang M; Trost N
J Med Imaging Radiat Oncol; 2012 Apr; 56(2):179-86. PubMed ID: 22498191
[TBL] [Abstract][Full Text] [Related]
5. Comparison of magnetic resonance imaging and (67)gallium scintigraphy in the evaluation of posttherapeutic residual mediastinal mass in the patients with Hodgkin's lymphoma.
Herman M; Paucek B; Raida L; Myslivecek M; Zapletalová J
Eur J Radiol; 2007 Dec; 64(3):432-8. PubMed ID: 17478069
[TBL] [Abstract][Full Text] [Related]
6. MRI patterns in recurrence of primary CNS lymphoma in immunocompetent patients.
Schulte-Altedorneburg G; Heuser L; Pels H
Eur J Radiol; 2012 Sep; 81(9):2380-5. PubMed ID: 21683538
[TBL] [Abstract][Full Text] [Related]
7. Differentiation of primary central nervous system lymphomas from high grade astrocytomas by qualitative analysis of the signal intensity curves derived from dynamic susceptibility-contrast magnetic resonance imaging.
Jensen-Kondering U; Henker C; Dörner L; Hugo HH; Jansen O
Neurol Res; 2012 Dec; 34(10):984-8. PubMed ID: 23146301
[TBL] [Abstract][Full Text] [Related]
8. Unusual uterine recurrence of primary central nervous system lymphoma.
Nichols GL; Jacobson CA; Ferman D; Lichtman SM
Clin Adv Hematol Oncol; 2006 Sep; 4(9):697-8, discussion 699-700. PubMed ID: 17099627
[No Abstract] [Full Text] [Related]
9. Ocular manifestation of primary nervous system lymphoma: what can be expected from imaging?
Küker W; Herrlinger U; Grönewäller E; Rohrbach JM; Weller M
J Neurol; 2002 Dec; 249(12):1713-6. PubMed ID: 12529795
[TBL] [Abstract][Full Text] [Related]
10. Analysis of perfusion weighted image of CNS lymphoma.
Lee IH; Kim ST; Kim HJ; Kim KH; Jeon P; Byun HS
Eur J Radiol; 2010 Oct; 76(1):48-51. PubMed ID: 19500931
[TBL] [Abstract][Full Text] [Related]
11. [A retrospective analysis of 8 cases with primary central nervous system lymphoma].
Zhou XQ; Liu XQ; Kong JC
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Oct; 23(5):455-7. PubMed ID: 12905861
[TBL] [Abstract][Full Text] [Related]
12. Differentiation of primary central nervous system lymphoma and high-grade glioma with dynamic susceptibility contrast-enhanced perfusion magnetic resonance imaging.
Liao W; Liu Y; Wang X; Jiang X; Tang B; Fang J; Chen C; Hu Z
Acta Radiol; 2009 Mar; 50(2):217-25. PubMed ID: 19096950
[TBL] [Abstract][Full Text] [Related]
13. [Primary lymphoma of the central nervous system: 20 years' experience in a referral hospital].
Calderón-Garcidueñas AL; Pacheco-Calleros J; Castelán-Maldonado E; Nocedal-Rustrián FC
Rev Neurol; 2008 Jan 16-31; 46(2):84-8. PubMed ID: 18247279
[TBL] [Abstract][Full Text] [Related]
14. Primary central nervous system lymphoma: an update.
Soussain C; Hoang-Xuan K
Curr Opin Oncol; 2009 Nov; 21(6):550-8. PubMed ID: 19684518
[TBL] [Abstract][Full Text] [Related]
15. CXCL13 and CXCL12 in central nervous system lymphoma patients.
Fischer L; Korfel A; Pfeiffer S; Kiewe P; Volk HD; Cakiroglu H; Widmann T; Thiel E
Clin Cancer Res; 2009 Oct; 15(19):5968-73. PubMed ID: 19773382
[TBL] [Abstract][Full Text] [Related]
16. [Malignant lymphoma in the central nervous system: overview].
Namekawa M
Brain Nerve; 2014 Aug; 66(8):907-16. PubMed ID: 25082313
[TBL] [Abstract][Full Text] [Related]
17. International study on low-grade primary central nervous system lymphoma.
Jahnke K; Korfel A; O'Neill BP; Blay JY; Abrey LE; Martus P; Poortmans PM; Shenkier TN; Batchelor TT; Neuwelt EA; Raizer JJ; Schiff D; Pels H; Herrlinger U; Stein H; Thiel E
Ann Neurol; 2006 May; 59(5):755-62. PubMed ID: 16586496
[TBL] [Abstract][Full Text] [Related]
18. Central nervous system recurrence in adult patients with acute lymphoblastic leukemia: frequency and prognosis in 467 patients without cranial irradiation for prophylaxis.
Sancho JM; Ribera JM; Oriol A; Hernandez-Rivas JM; Rivas C; Bethencourt C; Parody R; Deben G; Bello JL; Feliu E;
Cancer; 2006 Jun; 106(12):2540-6. PubMed ID: 16700036
[TBL] [Abstract][Full Text] [Related]
19. Treatment options for central nervous system lymphomas in immunocompetent patients.
Jahnke K; Thiel E
Expert Rev Neurother; 2009 Oct; 9(10):1497-509. PubMed ID: 19831839
[TBL] [Abstract][Full Text] [Related]
20. Patterns of treatment in older adults with primary central nervous system lymphoma.
Panageas KS; Elkin EB; Ben-Porat L; Deangelis LM; Abrey LE
Cancer; 2007 Sep; 110(6):1338-44. PubMed ID: 17647247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]